XML 30 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Options and Restricted Stock Units
12 Months Ended
Dec. 31, 2022
Stock Options and Restricted Stock Units  
Stock Options and Restricted Stock Units

Note 8: Stock Options and Restricted Stock Units

 

On May 23, 2014, the shareholders of the Company approved the 2014 Equity Incentive Plan (the “2014 Plan”). Under the terms of the 2014 Plan, the Company is authorized to issue incentive awards for common stock up to 200,000 shares to employees and other personnel. On June 10, 2016 and June 17, 2020, the shareholders of the Company approved an additional 200,000 and 200,000 awards, respectively, to be issued under the 2014 Plan, bringing the total number of shares to be awarded to 600,000. The awards may be in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units and performance awards. The 2014 Plan is effective through March 31, 2024. As of December 31, 2022, there are 130,995 shares which remain to be granted under the 2014 Plan.

 

The following is a summary of stock options issued during the year ended December 31, 2022 and 2021:

 

 

 

Number of Options

Outstanding

 

 

Range of

Exercise Price

 

 

Weighted Average

Exercise Price

 

 

Aggregate

Intrinsic Value

 

Balance on December 31, 2020

 

 

75,230

 

 

$

6.80 – 17.40

 

 

$12.16

 

 

$402,275

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(23,563 )

 

6.80 – 17.40

 

 

 

13.01

 

 

 

267,300

 

Options forfeited/cancelled

 

 

(4,500 )

 

9.26 – 13.21

 

 

 

11.45

 

 

 

62,385

 

Balance on December 31, 2021

 

 

47,167

 

 

$

6.80 – 17.40

 

 

$11.81

 

 

$832,254

 

Options granted

 

 

50,250

 

 

26.00 – 27.71

 

 

 

26.69

 

 

 

 

Options exercised

 

 

(10,000)

 

7.76 – 13.21

 

 

 

9.12

 

 

 

185,500

 

Options forfeited/cancelled

 

 

(6,167)

 

9.26 – 27.71

 

 

 

27.71

 

 

 

 

Balance on December 31, 2022

 

 

81,250

 

 

$

6.80 – 27.71

 

 

$20.17

 

 

 

462,390

 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e. the aggregate difference between the closing price of the Company’s common stock on December 31, 2022 and 2021 of $25.04 and $29.45, respectively, and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2022 and 2021. As of December 31, 2022, there was $403,000 of unrecognized compensation cost related to stock options, which will be recognized through 2026.

The following is a summary of unvested stock options during the year ended December 31, 2022 and 2021:

 

 

 

Number of Options

Outstanding

 

 

Weighted Average

Exercise Price

 

 

Weighted Average Grant Date Fair Value

 

Balance on December 31, 2020

 

 

14,500

 

 

$12.87

 

 

$5.47

 

Options vested

 

 

(14,500)

 

 

12.87

 

 

 

5.47

 

Options forfeited/cancelled

 

 

 

 

 

 

 

 

 

Balance on December 31, 2021

 

 

 

 

 

12.87

 

 

 

5.47

 

Options granted

 

 

50,250

 

 

 

26.69

 

 

 

12.54

 

Options vested

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(6,000)

 

 

27.71

 

 

 

13.53

 

Balance on December 31, 2022

 

 

44,250

 

 

$26.55

 

 

$12.41

 

 

The following table summarizes information about stock options outstanding and exercisable on December 31, 2022:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Price Range

 

Number

 

 

Weighted Average Remaining Contractual Life (in Years)

 

 

Weighted Average Exercise Price

 

 

Number

 

  $0.01 - 8.00 

 

 

7,500

 

 

 

2.17

 

 

 

7.12

 

 

 

7,500

 

  $8.01 - 11.00 

 

 

3,500

 

 

 

4.57

 

 

 

10.11

 

 

 

3,500

 

  $11.01 - 16.00 

 

 

18,000

 

 

 

5.53

 

 

 

13.12

 

 

 

18,000

 

  $16.01 - 27.00 

 

 

38,000

 

 

 

8.30

 

 

 

24.19

 

 

 

8,000

 

  $27.01 – 27.71 

 

 

14,250

 

 

 

9.05

 

 

 

27.71

 

 

 

 

    Total 

 

 

81,250

 

 

 

7.13

 

 

 

20.31

 

 

 

37,000

 

 

Of the 81,250 stock options outstanding, 36,366 are non-qualified stock options. All options have been registered with the SEC.

 

The fair value of common stock options issued during the year ended December 31, 2022 were estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions used:

 

 

 

Year Ended December 31,2022

 

Expected dividend yield

 

 

0%

Expected stock price volatility

 

 

46%

Weighted-average risk-free interest rate

 

 

1.68%

Weighted-average expected life of options (in years)

 

 

6.29

 

 

The following is a summary of restricted stock units issued during the years ended December 31, 2022 and 2021:

 

 

 

Number of RSUs Outstanding

 

 

Weighted Average Grant Date

Fair Value

 

 

Aggregate Intrinsic Value

 

Balance on December 31, 2020

 

 

19,000

 

 

$10.78

 

 

$332,690

 

Units granted

 

 

17,765

 

 

 

25.92

 

 

 

460,504

 

Units vested/issued

 

 

(19,000 )

 

 

10.78

 

 

 

464,400

 

Units forfeited

 

 

 

 

 

 

 

 

 

Balance on December 31, 2021

 

 

17,765

 

 

$25.92

 

 

$523,197

 

Units granted

 

 

48,240

 

 

 

24.99

 

 

 

1,205,525

 

Units vested/issued

 

 

(15,265 )

 

 

26.05

 

 

 

377,981

 

Units forfeited

 

 

 

 

 

 

 

 

 

Balance on December 31, 2022

 

 

50,740

 

 

25.00

 

 

1,268,500

 

During the year ended December 31, 2022, the Company granted 48,240 restricted stock units with an average grant date fair value of $24.99 per share to certain employees and non-employee members of the Board of Directors of the Company. Non-employee directors were granted 12,240 restricted stock units, which vest on the earlier of the 2023 annual meeting of the shareholders or one year. The other 36,000 restricted stock units were granted to employees of the Company. During the year ended December 31, 2022, 15,265 restricted stock units with an average grant date fair value of $26.05 vested. As of December 31, 2022, there was $843,000 of unrecognized compensation cost related to unvested restricted stock units, which will be recognized through 2025. All restricted stock units have been registered with the SEC.

 

During the years ended December 31, 2022 and 2021, the Company recorded compensation expense of $763,000 and $333,000, respectively, related to stock options and restricted stock units.